ID

32541

Descripción

A Study for Patients With Non-Hodgkin's Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT00542919

Link

https://clinicaltrials.gov/show/NCT00542919

Palabras clave

Versiones (1)
  1. 6/11/18 6/11/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

6 de noviembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility T-Cell Lymphoma NCT00542919

Inglés

Eligibility T-Cell Lymphoma NCT00542919

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
have measurable lesions
Descripción

Measurable lesion

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
have recovered from prior chemotherapies
Descripción

Prior Chemotherapy Patient recovered

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1115804
have an estimated life expectancy of at least 12 weeks
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
hepatic: total bilirubin less than or equal to 1.5 xuln; atl/ast less than or equal to 2.0 x uln (less than 5x if liver metastases are present)
Descripción

Liver function | Serum total bilirubin measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Relationship Secondary malignant neoplasm of liver

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201899
UMLS CUI [5,1]
C0439849
UMLS CUI [5,2]
C0494165
renal: serum creatinine less than or equal to 1.5xuln
Descripción

Renal function | Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
adequate bone marrow reserve: platelets greater than or equal to 75 x 109 /l, absolute neutrophil count (anc) greater than or equal to 1.0 x 09 /l
Descripción

Bone Marrow Mature Neutrophils Present Adequate | Platelet Count measurement | Absolute neutrophil count

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C1708947
UMLS CUI [1,3]
C0205411
UMLS CUI [2]
C0032181
UMLS CUI [3]
C0948762
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
have a second primary malignancy (except adequately treated nonmelanomatous skin cancer, or other cancer that is considered cured by surgical resection or radiation).
Descripción

Second Primary Cancer | Exception Skin carcinoma Treated | Exception Cancer Other Cured Excision | Exception Cancer Other Cured Therapeutic radiology procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0751623
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C1707251
UMLS CUI [3,3]
C1880198
UMLS CUI [3,4]
C0728940
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C1707251
UMLS CUI [4,3]
C1880198
UMLS CUI [4,4]
C1522449
anti-lymphoma therapy within the past 3 weeks
Descripción

Therapeutic procedure Against Lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0521124
UMLS CUI [1,3]
C0024299
unable to swallow tablets
Descripción

Lacking Able to swallow Tablets

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332268
UMLS CUI [1,2]
C2712086
UMLS CUI [1,3]
C0039225
unable to discontinue use of carbamazepine, phenobarbital and phenytoin at least 14 days prior to study enrollment
Descripción

Carbamazepine Discontinue Unable | Phenobarbital Discontinue Unable | Phenytoin Discontinue Unable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0006949
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C0031412
UMLS CUI [2,2]
C1444662
UMLS CUI [2,3]
C1299582
UMLS CUI [3,1]
C0031507
UMLS CUI [3,2]
C1444662
UMLS CUI [3,3]
C1299582
Volver a la parte superior de la página

Similar models

Eligibility T-Cell Lymphoma NCT00542919

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Measurable lesion
Item
have measurable lesions
boolean
C1513041 (UMLS CUI [1])
Prior Chemotherapy Patient recovered
Item
have recovered from prior chemotherapies
boolean
C1514457 (UMLS CUI [1,1])
C1115804 (UMLS CUI [1,2])
Life Expectancy
Item
have an estimated life expectancy of at least 12 weeks
boolean
C0023671 (UMLS CUI [1])
Liver function | Serum total bilirubin measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Relationship Secondary malignant neoplasm of liver
Item
hepatic: total bilirubin less than or equal to 1.5 xuln; atl/ast less than or equal to 2.0 x uln (less than 5x if liver metastases are present)
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201899 (UMLS CUI [4])
C0439849 (UMLS CUI [5,1])
C0494165 (UMLS CUI [5,2])
Renal function | Creatinine measurement, serum
Item
renal: serum creatinine less than or equal to 1.5xuln
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Bone Marrow Mature Neutrophils Present Adequate | Platelet Count measurement | Absolute neutrophil count
Item
adequate bone marrow reserve: platelets greater than or equal to 75 x 109 /l, absolute neutrophil count (anc) greater than or equal to 1.0 x 09 /l
boolean
C0005953 (UMLS CUI [1,1])
C1708947 (UMLS CUI [1,2])
C0205411 (UMLS CUI [1,3])
C0032181 (UMLS CUI [2])
C0948762 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Second Primary Cancer | Exception Skin carcinoma Treated | Exception Cancer Other Cured Excision | Exception Cancer Other Cured Therapeutic radiology procedure
Item
have a second primary malignancy (except adequately treated nonmelanomatous skin cancer, or other cancer that is considered cured by surgical resection or radiation).
boolean
C0751623 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C1707251 (UMLS CUI [3,2])
C1880198 (UMLS CUI [3,3])
C0728940 (UMLS CUI [3,4])
C1705847 (UMLS CUI [4,1])
C1707251 (UMLS CUI [4,2])
C1880198 (UMLS CUI [4,3])
C1522449 (UMLS CUI [4,4])
Therapeutic procedure Against Lymphoma
Item
anti-lymphoma therapy within the past 3 weeks
boolean
C0087111 (UMLS CUI [1,1])
C0521124 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
Lacking Able to swallow Tablets
Item
unable to swallow tablets
boolean
C0332268 (UMLS CUI [1,1])
C2712086 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,3])
Carbamazepine Discontinue Unable | Phenobarbital Discontinue Unable | Phenytoin Discontinue Unable
Item
unable to discontinue use of carbamazepine, phenobarbital and phenytoin at least 14 days prior to study enrollment
boolean
C0006949 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0031412 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
C0031507 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C1299582 (UMLS CUI [3,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial